|
rdfs:label
|
"Salazosulfapiridina"@it
"Sulfasalazin"@cs
"Sulfasalazin"@de
"Sulfasalazin"@id
"Sulfasalazin"@jv
"Sulfasalazin"@min
"Sulfasalazin"@sh
"Sulfasalazin"@sr-el
"Sulfasalazin"@su
"Sulfasalazin"@tr
"Sulfasalazină"@ro
"sulfasalatsiini"@fi
"sulfasalazin"@hr
"sulfasalazin"@nn
"sulfasalazin"@sl
"sulfasalazina"@ca
"sulfasalazina"@es
"sulfasalazine"@en
"sulfasalazine"@fr
"sulfasalazine"@nl
"sulfasalazine"@vi
"sulfasalazyna"@pl
"sulfassalazina"@pt
"sylffasalasin"@cy
"σουλφασαλαζίνη"@el
"Сулфасалазин"@sr
"Сулфасалазин"@sr-ec
"сульфасалазин"@ru
"сульфасалазин"@uk
"Սուլֆասալազին"@hy
"سلفاسالازين"@ar
"سولفاسالازین"@azb
"سولفاسالازین"@fa
"ସଲଫାସାଲାଜିନ"@or
"サラゾスルファピリジン"@ja
"柳氮磺胺吡啶"@yue
"柳氮磺胺吡啶"@zh
"설파살라진"@ko
|
|
skos:altLabel
|
"2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid"@en
"2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid"@en
"4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene"@en
"4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene"@cy
"5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid"@en
"5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid"@en
"5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid"@cy
"5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid"@en
"5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid"@cy
"5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid"@en
"5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid"@en
"5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid"@cy
"Azopyrin"@en
"Azulfidine"@sr
"Azulfidine"@de
"Azulfidine®"@en
"Azulfidine®"@cy
"C18H14N4O5S"@sr
"SAS-500"@en
"SAS-500"@cy
"Salazopyridin®"@en
"Salazopyridin®"@cy
"Salazopyrin"@sr
"Salazopyrine"@nl
"Salazopyrin®"@en
"Salazopyrin®"@cy
"Salazosulfapiridina"@en
"Salazosulfapyridin"@de
"Salazosulfapyridine"@en
"Salazosulfapyridine"@cy
"Salazosulfapyridinum"@en
"Salicylazosulfapyridine"@en
"Salicylazosulfapyridine"@cy
"Sulfasalazin"@en
"Sulfasalazina"@en
"Sulfasalazina"@it
"Sulfasalazine"@en
"Sulfasalazinum"@en
"ଆଜୁଲଫିଡ଼ିନ"@or
"スルファサラジン"@ja
"사라조피린EN"@ko
"사피루진이엔"@ko
"살라조피리딘"@ko
"살라조피린"@ko
"살라진"@ko
"아자설판"@ko
"아줄피딘"@ko
"조피린"@ko
|
|
schema:description
|
"Arzneistoff"@de
"cheemesch Verbindung"@lb
"chemical compound"@en
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"compositum chemicum"@la
"compost químic"@ca
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"farmaco"@it
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kimyasal bileşik"@tr
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"médicament"@fr
"sanyawa kimia"@min
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"χημική ένωση"@el
"хемиско соединение"@mk
"химическое соединение"@ru
"хімічна сполука"@uk
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"രാസസംയുക്തം"@ml
"항류마티스제"@ko
|
|
schema:dateModified
|
"2026-01-28T03:22:07+00:00"^^xsd:dateTime
|
|
schema:version
|
2458510003
|
|
wikibase:identifiers
|
49
|
|
wikibase:sitelinks
|
35
|
|
wikibase:statements
|
78
|
|
p:P10245
|
wd:statement/Q420035-c2ed4c1b-4287-1fbd-bdd6-1d9587d72c40
|
|
p:P10283
|
wd:statement/Q420035-2FBBCA3B-872C-4DB3-B94C-DA1DEC7988B4
|
|
p:P11143
|
wd:statement/Q420035-C5089D9F-9593-4C4A-A209-961D10145595
|
|
p:P11199
|
wd:statement/Q420035-78A1D58D-0B57-40A2-A64B-8315929B6A50
|
|
p:P117
|
wd:statement/Q420035-58D507C1-4ACF-4E91-9EEA-9045EB2FC50A
|
|
p:P11931
|
wd:statement/Q420035-f7669679-9e15-4126-a241-a1ad39276dc3
|
|
p:P1578
|
wd:statement/Q420035-42475FF3-E644-4330-89DB-3E2AFDBED851
|
|
p:P1579
|
wd:statement/Q420035-39550043-7036-40BD-8434-E44E22F838FE
|
|
wd:statement/Q420035-C23930E4-A949-45C6-9045-8CDCDAECEC67
|
|
p:P2017
|
wd:statement/Q420035-F408EB2B-A4B2-4E84-88C7-C23555E5DDC0
|
|
p:P2057
|
wd:statement/Q420035-82626BAA-D27F-460C-9C9B-32C5D7CBE3D0
|
|
p:P2062
|
wd:statement/Q420035-363E0511-F0D0-4F87-9FFA-7A4FE7C4A6BD
|
|
p:P2067
|
wd:statement/Q420035-E2F14D16-1F3F-4DC7-A592-3F5712C317F4
|
|
p:P2115
|
wd:statement/Q420035-D8CD568E-4464-445B-BB38-D8F1FDB62F1E
|
|
p:P2175
|
wd:statement/Q420035-1E880597-0DF3-4382-A3CA-6C15D753DCA8
|
|
wd:statement/Q420035-44CFB89C-3255-4DD2-AC7C-5E6BFDDF31DB
|
|
wd:statement/Q420035-53DE7456-4B04-475D-985B-CE5A2CA509B3
|
|
wd:statement/Q420035-A57368AE-9321-417D-9663-2F971A6E5FC3
|
|
p:P2275
|
wd:statement/Q420035-1551dffd-4b63-85d2-a45c-1dbd2cfcc87c
|
|
wd:statement/Q420035-CBAE22C0-2D05-4987-BBCC-0E2B7059A09E
|
|
p:P231
|
wd:statement/Q420035-16998230-E625-401F-99EB-75EEA65A5791
|
|
p:P232
|
wd:statement/Q420035-0FC10B2D-3355-4FD2-A89E-8855A3C595B7
|
|
p:P233
|
wd:statement/Q420035-ABDD95D7-3847-4D2E-81BE-16818FD9383D
|
|
p:P234
|
wd:statement/Q420035-7F116B4E-E972-42E3-8A3A-4D5F483F8D36
|
|
p:P235
|
wd:statement/Q420035-E79F1BC2-7800-4D05-91BB-573FBE8AC180
|
|
p:P2566
|
wd:statement/Q420035-13572468-2468-1357-eca9-bdf024681357
|
|
p:P267
|
wd:statement/Q420035-9F254A40-B156-48B3-8F1D-B4F15E1DBAA9
|
|
p:P274
|
wd:statement/Q420035-27D8D636-B127-4D6B-A0EC-A872C06804CE
|
|
p:P279
|
wd:statement/Q420035-56E3C8E2-5A14-47B6-B67D-7220FDDF914D
|
|
p:P2840
|
wd:statement/Q420035-0D14FAD7-C816-4719-81EF-70E98DABB8AB
|
|
wd:statement/Q420035-563B847F-9EAF-4A69-BD9E-BDC4A4B51BF7
|
|
wd:statement/Q420035-7D772E49-C436-4EA3-B110-89D96FCD6F17
|
|
p:P2868
|
wd:statement/Q420035-04C7BE9E-780E-4EE2-AE69-6F10C2DC148F
|
|
wd:statement/Q420035-5EFEEA32-5ACC-422D-9C07-3A71ADB8C435
|
|
wd:statement/Q420035-B850DA7A-1FA3-4343-AB19-E9A1E54DDC26
|
|
wd:statement/Q420035-CE48747A-13C3-4757-965B-5A6EA10F9F38
|
|
wd:statement/Q420035-D750944E-19B2-4BAE-B085-E6D20C120A7E
|
|
wd:statement/Q420035-E0E00D2D-BBDC-4081-BF6E-EC4856562892
|
|
wd:statement/Q420035-E57B1916-55D8-432B-873B-8FAD01959401
|
|
wd:statement/Q420035-F144838F-6ADC-41BD-9955-07ECAC3D5684
|
|
wd:statement/Q420035-F27BB80A-A36A-4E59-B6C5-C412B099CC7E
|
|
p:P2877
|
wd:statement/Q420035-FB897890-D172-40E0-B0CB-C9ACAD628D0C
|
|
p:P2892
|
wd:statement/Q420035-E53136E0-9D0E-4E21-97E5-EC30496A9662
|
|
p:P31
|
wd:statement/Q420035-1EF406A3-8767-4A2B-B670-870A006F07C2
|
|
p:P3117
|
wd:statement/Q420035-207BD37F-597D-4018-BA01-ED4F6A3C1569
|
|
p:P3345
|
wd:statement/Q420035-EA43EA7D-4257-4944-9B2C-59F578451C3C
|
|
p:P3636
|
wd:statement/Q420035-A23BD5F5-F67F-49A7-A717-4909B40E7524
|
|
p:P366
|
wd:statement/Q420035-B9C174C4-5B63-439E-BF88-68EBFF0D3BCC
|
|
p:P373
|
wd:statement/Q420035-570AB240-135B-4589-98EC-D8B94DE9FD4B
|
|
p:P3780
|
wd:statement/Q420035-36DCD84D-21B2-416D-A8BE-656DE1467874
|
|
wd:statement/Q420035-B0240A00-EF1E-437D-8BC8-D3207054D3D3
|
|
p:P4168
|
wd:statement/Q420035-D4454CED-645E-4F1C-96CC-AFF1EF438277
|
|
p:P486
|
wd:statement/Q420035-7702F344-7BF9-4905-A5EA-CA5B79686851
|
|
p:P4964
|
wd:statement/Q420035-0FFA698C-9070-437D-8CA3-96511ECDEFCD
|
|
p:P5082
|
wd:statement/Q420035-4e276b0d-6a77-4e94-88a0-49b42c8a9adc
|
|
p:P527
|
wd:statement/Q420035-4155AA13-7FAA-4480-8219-C182D085DA92
|
|
wd:statement/Q420035-67AA16A3-16EC-407B-9C93-1C26D13E5432
|
|
p:P592
|
wd:statement/Q420035-755F3859-99F5-4037-813F-3154874DBEAD
|
|
p:P595
|
wd:statement/Q420035-A501B4EF-CD8D-4D92-985A-736A401E38C2
|
|
p:P6366
|
wd:statement/Q420035-5DC895DF-4141-4B6F-B329-96EE9BF1384C
|
|
p:P638
|
wd:statement/Q420035-1BECD187-AFD6-43A2-BB05-83D83C41EC47
|
|
wd:statement/Q420035-A3CE88D6-6B7C-40DD-912F-106C01A0C35F
|
|
wd:statement/Q420035-DC104F01-CC76-4AD8-AF4A-E4FA8319A003
|
|
p:P646
|
wd:statement/Q420035-B93780E6-B74C-43FD-8B3C-9067770E9AF9
|
|
p:P652
|
wd:statement/Q420035-4526BBE6-BD0F-4FB7-ABBD-29E7D90A166D
|
|
p:P661
|
wd:statement/Q420035-18E4DD18-6E7B-4088-B63E-603461D95FA2
|
|
p:P662
|
wd:statement/Q420035-D824ABC7-F5AD-4F39-B9AC-B1632B231D55
|
|
p:P665
|
wd:statement/Q420035-04D456C8-AB0B-457F-B6D9-C2ABA0E9B8F2
|
|
wd:statement/Q420035-560C3EA6-D7B9-46EC-AB11-6511187C551F
|
|
p:P672
|
wd:statement/Q420035-51d5eb24-4d85-896e-0c0f-0c1c6678c06f
|
|
wd:statement/Q420035-f79e1dbe-44c6-31fd-7a65-4d7996925520
|
|
p:P683
|
wd:statement/Q420035-6DA00474-50E6-46EF-93B1-4D0AC08F7681
|
|
p:P715
|
wd:statement/Q420035-73FF94F8-769B-4A3A-A3E7-25A8ACD7C0C4
|
|
p:P7524
|
wd:statement/Q420035-E292C794-155D-4162-9B85-83B0C39BF670
|
|
p:P8494
|
wd:statement/Q420035-1FAFC94E-B8D9-4DD0-B569-2371715B1BC8
|
|
p:P9272
|
wd:statement/Q420035-998739B8-9D2D-4A91-9AA2-1C90C11BB38B
|
|
p:P9635
|
wd:statement/Q420035-BFCAB8A5-2887-47FA-8467-4C1558035C17
|
|
p:P9989
|
wd:statement/Q420035-96F7C693-539A-40ED-9201-AD9E6336E9AF
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000146249>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/D012460>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL421>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2779383735>
|
|
p:direct-normalized/P638
|
<https://rdf.wwpdb.org/pdb/13GS>
|
|
<https://rdf.wwpdb.org/pdb/4J7X>
|
|
<https://rdf.wwpdb.org/pdb/5ACL>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/10605946>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353980>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/C07316>
|
|
<http://www.kegg.jp/entry/D00448>
|
|
p:direct-normalized/P672
|
<http://id.nlm.nih.gov/mesh/D02.065.884.730>
|
|
<http://id.nlm.nih.gov/mesh/D02.886.590.700.730>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_9334>
|
|
wdt:P10245
|
"a682204"
|
|
wdt:P10283
|
"C2779383735"
|
|
wdt:P11143
|
"Sulfasalazine"
|
|
wdt:P11199
|
"PD001744"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Sulfasalazine.svg>
|
|
wdt:P11931
|
"20999"
|
|
wdt:P1578
|
"2666050"
|
|
wdt:P1579
|
"356241"
|
|
"8132868"
|
|
wdt:P2017
|
"C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)/N=N/C3=CC=C(C(=C3)C(=O)O)O"
|
|
wdt:P2057
|
"HMDB0014933"
|
|
wdt:P2062
|
"3395"
|
|
wdt:P2067
|
398.0685^^xsd:decimal
|
|
wdt:P2115
|
"N0000146249"
|
|
wdt:P2175
|
ulcerative colitis
|
|
arthritis
|
|
rheumatoid arthritis
|
|
juvenile rheumatoid arthritis
|
|
wdt:P2275
|
"sulfasalazin"@cs
"sulfasalazine"@en
|
|
wdt:P231
|
"599-79-1"
|
|
wdt:P232
|
"209-974-3"
|
|
wdt:P233
|
"C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC=C(C(=C3)C(=O)O)O"
|
|
wdt:P234
|
"InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+"
|
|
wdt:P235
|
"NCEXYHBECQHGNR-QZQOTICOSA-N"
|
|
wdt:P2566
|
"100.009.069"
|
|
wdt:P267
|
"A07EC01"
|
|
wdt:P274
|
"C₁₈H₁₄N₄O₅S"
|
|
wdt:P279
|
aminosalicylic acids
|
|
wdt:P2840
|
"203730"
|
|
"667219"
|
|
"757330"
|
|
wdt:P2868
|
5-lipoxygenase inhibitor
|
|
carcinogen
|
|
non-steroidal anti-inflammatory drug
|
|
cyclooxygenase inhibitors
|
|
WHO essential medicines
|
|
anti-infective agent
|
|
gastrointestinal agent
|
|
male reproductive toxicant
|
|
disease-modifying antirheumatic drug
|
|
wdt:P2877
|
"4515"
|
|
wdt:P2892
|
"C0036078"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID0021256"
|
|
wdt:P3345
|
"9524"
|
|
wdt:P3636
|
"SAS"
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Sulfasalazine"
|
|
wdt:P3780
|
Azulfidine
|
|
Sulfazine
|
|
wdt:P4168
|
"122672"
|
|
wdt:P486
|
"D012460"
|
|
wdt:P4964
|
"splash10-0002-0239100000-5bf223e6e250eb77105a"
|
|
wdt:P5082
|
"salazosulfapyridin"
|
|
wdt:P527
|
carbon
|
|
nitrogen
|
|
wdt:P592
|
"CHEMBL421"
|
|
wdt:P595
|
"4840"
|
|
wdt:P6366
|
"2779383735"
|
|
wdt:P638
|
"13GS"
|
|
"4J7X"
|
|
"5ACL"
|
|
wdt:P646
|
"/m/04jy5g"
|
|
wdt:P652
|
"3XC8GUZ6CB"
|
|
wdt:P661
|
"10605946"
|
|
wdt:P662
|
"5353980"
|
|
wdt:P665
|
"C07316"
|
|
"D00448"
|
|
wdt:P672
|
"D02.065.884.730"
|
|
"D02.886.590.700.730"
|
|
wdt:P683
|
"9334"
|
|
wdt:P715
|
"DB00795"
|
|
wdt:P7524
|
"sulfasalazine"
|
|
wdt:P8494
|
"DTXCID401256"
|
|
wdt:P9272
|
"12835"
|
|
wdt:P9635
|
"180"
|
|
wdt:P9989
|
"sulfaSALAzine"
|